Genome

Rome Therapeutics adds $72 million to Series B round to harness “dark genome”

14-Sep-2023 By Jonathan Smith

The U.S. company Rome Therapeutics plans to use the proceeds of its $72 million Series B round to take an experimental autoimmune disease treatment through early clinical testing.

Big pharma companies team up to increase diversity in genome data

20-Jul-2023 By Jonathan Smith

The pharma giants AbbVie, Amgen, AstraZeneca, Bayer and Merck have been revealed as founding members of the Alliance for Genomic Discovery (AGD), a project aiming to accelerate drug development by collecting genomic data from underrepresented populations.

MilliporeSigma and genOway enter CRISPR collaboration

19-Dec-2018 By Maggie Lynch

genOway has acquired exclusive rights to MilliporeSigma's genome-editing patents to produce and sell new rodent models.

DIA 2018

WCG, InformedDNA team up to support clinical trials using genetics, as pipelines shift to highly targeted therapies

16-Jul-2018 By Melissa Fassbender

WCG and InformedDNA have established a new center for genetics and precision medicine in clinical trials – the increasing complexity of which, while potentially daunting, also creates the opportunity for transformational value, say industry experts.

Zika vaccine-blocker candidate being tested in animals

14-Apr-2016 By Melissa Fassbender

Replikins’ genomic understanding of the Zika and Flaviviruses has led to the development of a trivalent vaccine for Zika, Dengue, and Japanese Encephalitis. 

Eisai inks R&D Genomics data deal; cuts 25% US jobs

13-Apr-2015 By Dan Stanton

Eisai has inked a deal with a genome analytics firm to aid drug discovery days after announcing it would be cutting 25% of its in-house US workforce.

Incyte calls time on selling gene data

03-Feb-2004

US company Incyte Genomics is closing down its Palo Alto-based gene
information division, saying that the availability of free genetic
databases on the Internet has scuppered the unit's business.

More whole genome arrays launched

07-Oct-2003

New microarray products covering the human genome have been
launched by MWG Biotech and Agilent Technologies, adding to the
choice of products available to researchers.

The new face of genomics

25-Apr-2003

Prominent US genomics Robert L. Strausberg, who directs the
National Cancer Institute's (NCI) Cancer Genomics office, has been
named as vice president for research at The Institute for Genomic
Research (TIGR).